Chidiac, Peter <br/><br/>
The eIF2B-interacting domain of RGS2 protects against GPCR agonist-induced hypertrophy in neonatal rat cardiomyocytes.  [electronic resource] 

 -  Cellular signalling  Jun 2014 
 - 1226-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-3913 
<br/><br/><label>Standard No.: </label>10.1016/j.cellsig.2014.02.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Cardiomegaly--metabolism<br/>Cell Size--drug effects<br/>Cells, Cultured<br/>Cyclic AMP--metabolism<br/>Eukaryotic Initiation Factor-2B<br/>Gene Expression<br/>Inositol Phosphates--metabolism<br/>Isoproterenol--pharmacology<br/>Myocytes, Cardiac--drug effects<br/>Phenylephrine--pharmacology<br/>Protein Biosynthesis<br/>Protein Interaction Domains and Motifs<br/>RGS Proteins--chemistry<br/>Rats<br/>Receptors, G-Protein-Coupled--agonists<br/>Second Messenger Systems